Sun, L., He, Y., Xu, L., Zhao, F., Zhou, Y., Zhang, L., Peng, Q., Zhang, H., Zhang, Q., Cao, T., Song, Y., Wang, S., Rao, M., Jia, X., Liu, X., Zhou, J., Ju, B., Wang, H., & Liu, J. (n.d.). higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China. Journal of acquired immune deficiency syndromes, 91, S8–S15. http://access.bl.uk/ark:/81055/vdc_100167545330.0x00000a